These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38842787)

  • 41. Artificial intelligence electrocardiogram as a novel screening tool to detect a newly abnormal left ventricular ejection fraction after anthracycline-based cancer therapy.
    Jacobs JEJ; Greason G; Mangold KE; Wildiers H; Willems R; Janssens S; Noseworthy P; Lopez-Jimenez F; Voigt JU; Friedman P; Van Aelst L; Vandenberk B; Attia ZI; Herrmann J
    Eur J Prev Cardiol; 2024 Mar; 31(5):560-566. PubMed ID: 37943680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term prognostic value of right ventricular dysfunction on cardiovascular magnetic resonance imaging in anthracycline-treated cancer survivors.
    Chhikara S; Hooks M; Athwal PSS; Hughes A; Ismail MF; Joppa S; Velangi PS; Nijjar PS; Blaes AH; Shenoy C
    Eur Heart J Cardiovasc Imaging; 2022 Aug; 23(9):1222-1230. PubMed ID: 34297807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Update on pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity.
    Corremans R; Adão R; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
    Clin Exp Pharmacol Physiol; 2019 Mar; 46(3):204-215. PubMed ID: 30244497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiotoxicity of Cancer Treatments: Focus on Anthracycline Cardiomyopathy.
    Nishi M; Wang PY; Hwang PM
    Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2648-2660. PubMed ID: 34587760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors.
    Bansal N; Adams MJ; Ganatra S; Colan SD; Aggarwal S; Steiner R; Amdani S; Lipshultz ER; Lipshultz SE
    Cardiooncology; 2019; 5():18. PubMed ID: 32154024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adriamycin-associated cardiomyopathy: where are we now? updates in pathophysiology, dose recommendations, prognosis, and outcomes.
    Hardaway BW
    Curr Opin Cardiol; 2019 May; 34(3):289-295. PubMed ID: 30973398
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients from Southern Sri Lanka: An Echocardiographic Analysis.
    Sandamali JAN; Hewawasam RP; Fernando MACSS; Jayatilaka KAPW; Madurawe RD; Sathananthan PP; Ekanayake U; Horadugoda J
    Biomed Res Int; 2020; 2020():1847159. PubMed ID: 33274195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anthracycline-induced cardiotoxicity.
    Shan K; Lincoff AM; Young JB
    Ann Intern Med; 1996 Jul; 125(1):47-58. PubMed ID: 8644988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of cardiotoxicity of anthracycline-containing chemotherapy regimens in patients with bone and soft tissue sarcomas: A study of the FDA adverse event reporting system joint single-center real-world experience.
    Mo Z; Deng Y; Bao Y; Liu J; Jiang Y
    Cancer Med; 2023 Dec; 12(24):21709-21724. PubMed ID: 38054208
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of Chemotherapy Induced Cardiomyopathy.
    Payne DL; Nohria A
    Curr Heart Fail Rep; 2017 Oct; 14(5):398-403. PubMed ID: 28779279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anthracycline-Induced Cardiotoxicity: Causes, Mechanisms, and Prevention.
    Bhagat A; Kleinerman ES
    Adv Exp Med Biol; 2020; 1257():181-192. PubMed ID: 32483740
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anthracycline Chemotherapy-Induced Cardiotoxicity in Breast Cancer Survivors: A Systematic Review.
    Lin KJ; Lengacher CA
    Oncol Nurs Forum; 2019 Sep; 46(5):E145-E158. PubMed ID: 31424455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does anthracycline-based chemotherapy in pregnant women with cancer offer safe cardiac and neurodevelopmental outcomes for the developing fetus?
    Framarino-Dei-Malatesta M; Sammartino P; Napoli A
    BMC Cancer; 2017 Nov; 17(1):777. PubMed ID: 29162041
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiotoxicity screening of long-term, breast cancer survivors-The CAROLE (Cardiac-Related Oncologic Late Effects) Study.
    Puckett LL; Saba SG; Henry S; Rosen S; Rooney E; Filosa SL; Gilbo P; Pappas K; Laxer A; Eacobacci K; Kapyur AN; Robeny J; Musial S; Chaudhry A; Chaudhry R; Lesser ML; Riegel A; Ramoutarpersaud S; Rahmani N; Shah A; Papas V; Dawodu T; Charlton J; Knisely JPS; Lee L
    Cancer Med; 2021 Aug; 10(15):5051-5061. PubMed ID: 34245128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anthracycline-induced cardiotoxicity - are we about to clear this hurdle?
    Dempke WCM; Zielinski R; Winkler C; Silberman S; Reuther S; Priebe W
    Eur J Cancer; 2023 May; 185():94-104. PubMed ID: 36966697
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pathogenesis, prevention and detection of cardiotoxicity of anthracycline cytostatic agents].
    Mladosievicová B; Hulín I; Krcméry V; Petrásová H; Kollárová H
    Bratisl Lek Listy; 1994 Jul; 95(7):304-22. PubMed ID: 7812833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiotoxicity in anthracycline therapy: Prevention strategies.
    Cruz M; Duarte-Rodrigues J; Campelo M
    Rev Port Cardiol; 2016 Jun; 35(6):359-71. PubMed ID: 27255173
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biomarkers for the early detection of anthracycline-induced cardiotoxicity: current status.
    Horacek JM; Vasatova M; Pudil R; Tichy M; Zak P; Jakl M; Jebavy L; Maly J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Dec; 158(4):511-7. PubMed ID: 24457832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Cardiooncology: Current Aspects of Prevention of Anthracycline Toxicity].
    Vasyuk YA; Shkolnik EL; Nesterov VV; Shkolnik LD; Varlan GV
    Kardiologiia; 2016 Dec; 56(12):72-79. PubMed ID: 28290807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Body Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer.
    Kotwinski P; Smith G; Cooper J; Sanders J; Ma L; Teis A; Kotwinski D; Mythen M; Pennell DJ; Jones A; Montgomery H;
    PLoS One; 2016; 11(12):e0165262. PubMed ID: 27911951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.